Ab Index-Nr. 009-017-00-8

Index-Nr.Internationale chemische BezeichnungEG-Nr.CAS-Nr.EinstufungKennzeichnungbis 30.11.2018: Spezifische Konzentrations-
grenzen,
M-Faktoren
ab 01.12.2018: Spezifische Konzentrations-
grenzen
M-Faktoren und ATE
Anmer-
kungen
Gefahrenklasse, Gefahren-
kategorie und Gefahren-
kodierung
Kodierung der Gefahrenhin-
weise
Piktogramm, Kodierung der SignalworteKodierung der Gefahrenhin-
weise
Kodierung der ergänzenden Gefahren-
merkmale
009-017-00-8potassium mu-fluoro-bis(triethylaluminium)400-040-212091-08-6Flam. Sol. 1
Water-react. 1
Skin Corr. 1A
Acute Tox. 4 *
H228
H270
H314
H332
GHS02
GHS05
GHS07
Dgr
H228
H270
H314
H332
EUH014 T
009-018-00-3magnesium hexafluorosilicate241-022-216949-65-8Acute Tox. 3 *H301GHS06
Dgr
H301 * 
011-001-00-0sodium231-132-97440-23-5Water-react. 1
Skin Corr. 1B
H260
H314
GHS02
GHS05
Dgr
H260
H314
EUH014  
011-002-00-6sodium hydroxide;
caustic soda
215-185-51310-73-2Skin Corr. 1AH314GHS05
Dgr
H314 Skin Corr. 1A;
H314: C ≥ 5 %
Skin Corr. 1B;
H314: 2 % ≤ C < 5 %
Skin Irrit. 2;
H315: 0,5 % ≤ C < 2%
Eye Irrit. 2; H319: 0,5 % ≤ C < 2 %
 
011-003-00-1sodium peroxide215-209-41313-60-6Ox. Sol. 1
Skin Corr. 1A
H271
H314
GHS03
GHS05
Dgr
H271
H314
   
011-004-00-7sodium azide247-852-126628-22-8Acute Tox. 2 *
Aquatic Acute 1
Aquatic Chronic 1
H300
H400
H410
GHS06
GHS09
Dgr
H300
H400
H410
EUH032  
011-005-00-2sodium carbonate207-838-8497-19-8Eye Irrit. 2H319GHS07
Wng
H319   
011-006-00-8sodium cyanate213-030-6917-61-3Acute Tox. 4 *
Aquatic Chronic 3
H302
H412
GHS07
Wng
H302
H412
   
011-007-00-3propoxycarbazone-sodium181274-15-7Aquatic Acute 1
Aquatic Chronic 1
H400
H410
GHS09
Wng
H410 M = 10 
012-001-00-3magnesium powder (pyrophoric)231-104-67439-95-4Water-react. 1
Pyr. Sol. 1
H260
H250
GHS02
Dgr
H260
H250
  T
012-002-00-9magnesium, powder or turnings231-104-6Flam. Sol. 1
Water-react. 2
Self-heat. 1
H228
H261
H252
GHS02
Dgr
H228
H261
H252
  T
012-003-00-4magnesium alkylsPyr. Liq. 1
Water-react. 1
Skin Corr. 1B
H250
H260
H314
GHS02
GHS05
Dgr
H250
H260
H314
EUH014 A
012-004-00-Xaluminium-magnesium-carbonate-
hydroxide-perchlorate-hydrate
422-150-1Aquatic Acute 1
Aquatic Chronic 1
H400
H410
GHS09
Wng
H410   
013-001-00-6aluminium powder (pyrophoric)231-072-37429-90-5Water-react. 2
Pyr. Sol. 1
H261
H250
GHS02
Dgr
H261
H250
  T
013-002-00-1aluminium powder (stabilised)231-072-37429-90-5Water-react. 2
Flam. Sol. 1
H261
H228
GHS02
Dgr
H261
H228
  T
013-003-00-7aluminium chloride, anhydrous231-208-17446-70-0Skin Corr. 1BH314GHS05
Dgr
H314   
013-004-00-2aluminium alkylsPyr. Liq. 1
Water-react. 1
Skin Corr. 1B
H250
H260
H314
GHS02
GHS05
Dgr
H250
H260
H314
EUH014 A
013-005-00-8diethyl(ethyldimethylsilanolato)aluminium401-160-855426-95-4Water-react. 1
Pyr. Liq. 1
Skin Corr. 1A
H260
H250
H314
GHS02
GHS05
Dgr
H260
H250
H314
EUH014  
013-006-00-3(ethyl-3-oxobutanoato-O'1,O'3)(2-dimethy-
laminoethanolato)(1-methoxypropan-2-
olato)aluminium(III), dimerised
402-370-2Flam. Liq. 3
Eye Dam. 1
H226
H318
GHS02
GHS05
Dgr
H226
H318
   
013-007-00-9poly(oxo(2-butoxyethyl-3-oxobutanoato-
O'1,O'3)aluminium)
403-430-0Eye Dam. 1H318GHS05
Dgr
H318   
013-008-00-4di-n-octylaluminium iodide408-190-07585-14-0Pyr. Liq. 1
Skin Corr. 1B
Aquatic Acute 1
Aquatic Chronic 1
H250
H314
H400
H410
GHS02
GHS05
GHS09
Dgr
H250
H314
H410
EUH014  
013-009-00-Xsodium (n-butyl)x(ethyl)y-1,5-dihydro)alu-
minate x = 0.5 y = 1.5
418-720-2Flam. Sol. 1
Water-react. 1
Pyr. Sol. 1
Acute Tox. 4 *
Skin Corr. 1A
H228
H260
H250
H332
H314
GHS02
GHS05
GHS07
Dgr
H228
H260
H250
H332
H314
EUH014 T
013-010-00-5hydroxy aluminium bis(2,4,8,10-
tetra-tert-butyl-6-hydroxy-12H-
dibenzo[d,g][1.3.2]dioxaphosphocin-
6-oxide)
430-650-4151841-65-5Aquatic Chronic 2H411GHS09H411   
014-001-00-9trichlorosilane233-042-510025-78-2Flam. Liq. 1
Pyr. Liq. 1
Acute Tox. 4 *
Acute Tox. 4 *
Skin Corr. 1A
H224
H250
H332
H302
H314
GHS02
GHS05
GHS07
Dgr
H224
H250
H332
H302
H314
EUH014
EUH029
*
STOT SE 3;
H335: C ≥ 1 %
T
014-002-00-4silicon tetrachloride233-054-010026-04-7Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
H319
H335
H315
GHS07
Wng
H319
H335
H315
EUH014  
014-003-00-Xdimethyldichlorosilane200-901-075-78-5Flam. Liq. 2
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
H225
H319
H335
H315
GHS02
GHS07
Dgr
H225
H319
H335
H315
   
014-004-00-5trichloro(methyl)silane;
methyltrichlorosilane
200-902-675-79-6Flam. Liq. 2
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
H225
H319
H335
H315
GHS02
GHS07
Dgr
H225
H319
H335
H315
EUH014Skin Irrit. 2;
H315: C ≥ 1 %
Eye Irrit. 2; H319:
C ≥ 1%
STOT SE 3;
H335: C ≥ 1 %
 
014-005-00-0tetraethyl silicate;
ethyl silicate
201-083-878-10-4Flam. Liq. 3
Acute Tox. 4 *
Eye Irrit. 2
STOT SE 3
H226
H332
H319
H335
GHS02
GHS07
Wng
H226
H332
H319
H335
   
014-006-00-6bis(4-fluorophenyl)-methyl-(1,2,4-triazol-4-
ylmethyl)silane hydrochloride
401-380-4Eye Irrit. 2
Aquatic Chronic 2
H319
H411
GHS07
GHS09
Wng
H319
H411
   
014-007-00-1triethoxyisobutylsilane402-810-317980-47-1Skin Irrit. 2H315GHS07
Wng
H315   
014-008-00-7(chloromethyl)bis(4-fluorophenyl)methylsi-
lane
401-200-485491-26-5Aquatic Chronic 2H411GHS09H411   
014-009-00-2isobutylisopropyldimethoxysilane402-580-4111439-76-0Flam. Liq. 3
Acute Tox. 4 *
Skin Irrit. 2
H226
H332
H315
GHS02
GHS07
Wng
H226
H332
H315
   
014-010-00-8disodium metasilicate229-912-96834-92-0Skin Corr. 1B
STOT SE 3
H314
H335
GHS05
GHS07
Dgr
H314
H335
   
014-011-00-3cyclohexyldimethoxymethylsilane402-140-117865-32-6Skin Irrit. 2
Aquatic Chronic 2
H315
H411
GHS07
GHS09
Wng
H315
H411
   
014-012-00-9bis(3-(trimethoxysilyl)propyl)amine403-480-3Eye Dam. 1
Aquatic Chronic 2
H318
H411
GHS05
GHS09
Dgr
H318
H411
   
014-013-00-4α-hydroxypoly(methyl-(3-(2,2,6,6-tetrame-
thylpiperidin-4-yloxy)propyl)siloxane)
404-920-7Acute Tox. 4 *
Acute Tox. 4 *
Skin Corr. 1B
Aquatic Chronic 2
H312
H302
H314
H411
GHS05
GHS07
GHS09
Dgr
H312
H302
H314
H411
   
014-014-00-Xetacelasil (ISO);
6-(2-chloroethyl)-6-(2-methoxyethoxy)-
2,5,7,10-tetraoxa-6-silaundecane
253-704-737894-46-5Repr. 1B
Acute Tox. 4 *
STOT RE 2 *
H360D ***
H302
H373 **
GHS08
GHS07
Dgr
H360D ***
H302
H373 **
   
014-015-00-5α-trimethylsilanyl-ω-trimethylsiloxypoly[oxy
(methyl-3-(2-(2-methoxypropoxy)propoxy)
propylsilanediyl]- co-oxy(dimethylsilane))
406-420-469430-40-6Aquatic Chronic 4H413H413   
014-016-00-0reaction mass of: 1,3-dihex-5-en-1-yl-
1,1,3,3-tetramethyldisiloxane;
1,3-dihex-n-en-1-yl-1,1,3,3-tetramethyldisi-
loxane
406-490-6Aquatic Chronic 2H411GHS09H411   
014-017-00-6flusilazole (ISO);
bis(4-fluorophenyl)(methyl)(1H–1,2,4-tria-
zol-1-ylmethyl)silane
85509-19-9Carc. 2
Repr. 1B
Acute Tox. 4 *
Aquatic Chronic 2
H351
H360D ***
H302
H411
GHS08
GHS07
GHS09
Dgr
H351
H360D ***
H302
H411
   
014-018-00-1octamethylcyclotetrasiloxane209-136-7556-67-2Repr. 2
Aquatic Chronic 4
H361f ***
H413
GHS08
Wng
H361f ***
H413
   
014-019-00-7reaction mass of: 4-[[bis-(4-fluorophenyl)
methylsilyl]methyl]-4H–1,2,4-triazole;
1-[[bis-(4-fluorophenyl)methylsilyl]methyl]-
1H–1,2,4-triazole
403-250-2Carc. 2
Repr. 1B
Acute Tox. 4 *
Aquatic Chronic 2
H351
H360D ***
H302
H411
GHS08
GHS07
GHS09
Dgr
H351
H360D ***
H302
H411
   
014-020-00-2bis(1,1-dimethyl-2-propynyloxy)dimethylsi-
lane
414-960-753863-99-3Acute Tox. 4 *H332GHS07
Wng
H332   
014-021-00-8tris(isopropenyloxy)phenyl silane411-340-852301-18-5Aquatic Acute 1
Aquatic Chronic 1
H400
H410
GHS09
Wng
H400
H410
   
014-022-00-3reaction product of: (2-hydroxy-4-(3-prope-
noxy)benzophenone and triethoxysilane)
with (hydrolysis product of silica and
methyltrimethoxysilane)
401-530-9Flam. Sol. 1
STOT SE 1
Acute Tox. 4 *
Acute Tox. 4 *
Acute Tox. 4 *
H228
H370 **
H332
H312
H302
GHS02
GHS08
GHS07
Dgr
H228
H370 **
H332
H312
H302
  T
014-023-00-9α, ω-dihydroxypoly(hex-5-en-1-ylmethylsi-
loxane)hoxysilane with (hydrolysis product
of silica and methyltrimethoxysilane)iazole
408-160-7125613-45-8Aquatic Chronic 2H411GHS09H411   
014-024-00-41-((3-(3-chloro-4-fluorophenyl)propyl)dime-
thylsilanyl)-4-ethoxybenzene
412-620-2121626-74-2Aquatic Chronic 2H411GHS09H411   
014-025-00-X4-[3-(diethoxymethylsilylpropoxy)-2,2,6,6-
tetramethyl]piperidine
411-400-3102089-33-8Acute Tox. 4 *
STOT RE 2 *
Skin Irrit. 2
Eye Dam. 1
Aquatic Chronic 3
H302
H373 **
H315
H318
H412
GHS08
GHS05
GHS07
Dgr
H302
H373 **
H315
H318
H412
   
014-026-00-5dichloro-(3-(3-chloro-4-fluorophenyl)pro-
pyl)methylsilane
407-180-3770722-36-6Skin Corr. 1AH314GHS05
Dgr
H314   
014-027-00-0chloro(3-(3-chloro-4-fluorophenyl)propyl)
dimethylsilane
410-270-5770722-46-8Skin Corr. 1AH314GHS05
Dgr
H314   
014-028-00-6α-[3-(1-oxoprop-2-eny)l-1-oxypropyl]dime-
thoxysilyloxy-ω-[3(1-oxoprop-2-enyl)-1-
oxypropyl]dimethoxysilyl poly(dimethylsilo-
xane)
415-290-8193159-06-7Skin Sens. 1H317GHS07
Wng
H317   
014-029-00-1O,O'-(ethenylmethylsilylene)di[(4-methyl-
pentan-2-one)oxime]
421-870-1156145-66-3Repr. 2
Acute Tox. 4 *
STOT RE 2 *
H361f ***
H302
H373 **
GHS08
GHS07
Wng
H361f ***
H302
H373 **
   
014-030-00-7[(dimethylsilylene)bis((1,2,3,3a,7a-η)-1H-
inden-1-ylidene)dimethyl]hafnium
422-060-0137390-08-0Acute Tox. 2 *H300GHS06
Dgr
H300   
014-031-00-2bis(1-methylethyl)-dimethoxysilane421-540-718230-61-0Flam. Liq. 3
Skin Irrit. 2
Skin Sens. 1
Aquatic Chronic 3
H226
H315
H317
H412
GHS02
GHS07
Wng
H226
H315
H317
H412
   
014-032-00-8dicyclopentyldimethoxysilane404-370-8126990-35-0Skin Irrit. 2
Eye Dam. 1
Aquatic Acute 1
Aquatic Chronic 1
H315
H318
H400
H410
GHS05
GHS09
Dgr
H315
H318
H410
   
014-033-00-32-methyl-3-(trimethoxysilyl)propyl-
2-propenoate hydrolysis product
with silica
419-030-4125804-20-8Flam. Liq. 2
Eye Irrit. 2
STOT SE 3
H225
H319
H336
GHS02
GHS07
Dgr
H225
H319
H336
   
014-034-00-93-hexylheptamethyltrisiloxane428-700-51873-90-1Acute Tox. 4 *
Aquatic Chronic 4
H332
H413
GHS07
Wng
H332
H413
   
014-035-00-42-(3,4-epoxycyclohexyl)
ethyltriethoxy silane
425-050-410217-34-2Skin Sens. 1
Aquatic Chronic 3
H317
H412
GHS07
Wng
H317
H412
   
014-036-00-X(4-ethoxyphenyl)(3-(4-fluoro-3-
phenoxyphenyl)propyl)dimethylsilane
405-020-7105024-66-6Repr. 1B
Aquatic Acute 1
Aquatic Chronic 1
H360F ***
H400
H410
GHS08
GHS09
Dgr
H360F ***
H410
 M = 1000 
014-037-00-52-butanone-O,O´,O´´-
(phenylsilylidyne)trioxime
433-360-634036-80-1STOT RE 2 *
Skin Sens. 1
Aquatic Chronic 3
H373 **
H317
H412
GHS08
GHS07
Wng
H373 **
H317
H412
   
014-038-00-0S-(3-(triethoxysilyl)propyl) octanethi-
oate
436-690-9220727-26-4Skin Sens. 1H317GHS07
Wng
H317   
014-039-00-6(2,3-dimethylbut-2-yl)-
trimethoxysilane
439-360-2142877-45-0Skin Irrit. 2
Eye Dam. 1
Aquatic Chronic 3
H315
H318
H412
GHS05
Dgr
H315
H318
H412
   
014-041-00-7N,N-
bis(trimethylsilyl)aminopropyl-
methyldiethoxysilane
445-890-5201290-01-9Acute Tox. 4 *
Skin Sens. 1
H302
H317
GHS07
Wng
H302
H317
   
014-042-00-2reaction mass of: O,O´,O´´,O´´´-
silanetetrayl tetrakis(4-methyl-2-
pentanone oxime) (3 stereoisomers)
423-010-0Eye Dam. 1H318GHS05
Dgr
H318   
014-043-00-8reaction product of amorphous silica
(50-85 %), butyl (1-methylpropyl)
magnesium (3-15 %), tetraethyl orthosilicate (5-15 %) and titanium
tetrachloride (5-20 %)
432-200-2STOT SE 3
Skin Irrit. 2
Eye Dam. 1
Aquatic Chronic 3
H335
H315
H318
H412
GHS05
GHS07
Dgr
H335
H315
H318
H412
   
014-044-00-33-[(4´-acetoxy-3´-methoxyphenyl)
propyl]trimethoxysilane
433-050-0Aquatic Chronic 2H411GHS09H411   
014-045-00-9magnesium sodium fluoride silicate442-650-1STOT RE 2 *H373 **GHS08
Wng
H373 **   
ab 01.03.2018*):
*) Die harmonisierten Einstufungen dürfen bereits vor dem genannten Datum verwendet werden.
014-046-00-4
E-Glas-Mikrofasern in repräsentativer Zusammensetzung; [ungerichtete Calcium-Aluminium-Silicat-Fasern mit folgender repräsentativer Zusammensetzung (Angabe in % Massenanteil): SiO2 50,0–56,0 %, Al2O3 13,0–16,0 %, B2O3 5,8–10,0 %, Na2O < 0,6 %, K2O < 0,4 %, CaO 15,0–24,0 %, MgO < 5,5 %, Fe2O3 < 0,5 %, F2 < 1,0 %.
Verfahren: Herstellung typischerweise im Düsenblasverfahren oder im Schleuderverfahren. (Weitere Einzelelemente können in geringen Mengen vorhanden sein. Die Verfahrensliste schließt Innovationen nicht aus).]
Carc. 1BH350iGHS08
Dgr
H350i)  A
ab 01.03.2018*):
*) Die harmonisierten Einstufungen dürfen bereits vor dem genannten Datum verwendet werden.
014-047-00-X
Glas-Mikrofasern in repräsentativer Zusammensetzung; [ungerichtete Calcium-Aluminium-Silicat-Fasern mit folgender Zusammensetzung (Angabe in % Massenanteil): SiO2 55,0-60,0 %, Al2O3 4,0–7,0 %, B2O3 8,0–11,0 %, ZrO2 0,0–4,0 %, Na2O 9,5–13,5 %, K2O 0,0–4,0 %, CaO 1,0–5,0 %, MgO 0,0–2,0 %, Fe2O3 < 0,2 %, ZnO 2,0–5,0 %, BaO 3,0–6,0 %, F2 < 1,0 %.
Verfahren: Herstellung typischerweise im Düsenblasverfahren oder im Schleuderverfahren. (Weitere Einzelelemente können in geringen Mengen vorhanden sein. Die Verfahrensliste schließt Innovationen nicht aus).]
Carc. 2H351 (Einatmen)GHS08
Wng
H351 (Einatmen)  A
015-001-00-1white phosphorus231-768-712185-10-3Pyr. Sol. 1
Acute Tox. 2 *
Acute Tox. 2 *
Skin Corr. 1A
Aquatic Acute 1
H250
H330
H300
H314
H400
GHS02
GHS06
GHS05
GHS09
Dgr
H250
H330
H300
H314
H400
   
015-002-00-7red phosphorus231-768-77723-14-0Flam. Sol. 1
Aquatic Chronic 3
H228
H412
GHS02
Dgr
H228
H412
   
015-003-00-2Calciumphosphid;
Tricalciumdiphosphid
215-142-01305-99-3Water-react. 1
Acute Tox. 2
Acute Tox. 3
Acute Tox. 1
Eye Dam. 1
Aquatic Acute 1
H260
H300
H311
H330
H318
H400
GHS02
GHS06
GHS05
GHS09
Dgr
H260
H300
H311
H330
H318
H400
EUH029
EUH032
M = 100 
015-004-00-8aluminium phosphide244-088-020859-73-8Water-react. 1
Acute Tox. 2
Acute Tox. 3
Acute Tox. 1
Aquatic Acute 1
H260
H300
H311
H330
H400
GHS02
GHS06
GHS09
Dgr
H260
H300
H311
H330
H400
EUH029
EUH032
M = 100 
015-005-00-3magnesium phosphide;
trimagnesium diphosphide
235-023-712057-74-8Water-react. 1
Acute Tox. 2
Acute Tox. 3
Acute Tox. 1
Aquatic Acute 1
H260
H300
H311
H330
H400
GHS02
GHS06
GHS09
Dgr
H260
H300
H311
H330
H400
EUH029
EUH032
M = 100 
015-006-00-9trizinc diphosphide;
zinc phosphide
215-244-51314-84-7Water-react. 1
Acute Tox. 2 *
Aquatic Acute 1
Aquatic Chronic 1
H260
H300
H400
H410
GHS02
GHS06
GHS09
Dgr
H260
H300
H410
EUH029
EUH032
M = 100T
015-007-00-4phosphorus trichloride231-749-37719-12-2Acute Tox. 2 *
Acute Tox. 2 *
STOT RE 2 *
Skin Corr. 1A
H330
H300
H373 **
H314
GHS06
GHS08
GHS05
Dgr
H330
H300
H373 **
H314
EUH014
EUH029
  
015-008-00-Xphosphorus pentachloride233-060-310026-13-8Acute Tox. 2 *
Acute Tox. 4 *
STOT RE 2 *
Skin Corr. 1B
H330
H302
H373 **
H314
GHS06
GHS08
GHS05
Dgr
H330
H302
H373 **
H314
EUH014
EUH029
  
015-009-00-5phosphoryl trichloride233-046-710025-87-3Acute Tox. 2 *
STOT RE 1
Acute Tox. 4 *
Skin Corr. 1A
H330
H372 **
H302
H314
GHS06
GHS08
GHS05
Dgr
H330
H372 **
H302
H314
EUH014
EUH029
  
015-010-00-0phosphorus pentoxide215-236-11314-56-3Skin Corr. 1AH314GHS05
Dgr
H314   
015-011-00-6phosphoric acid ... %, orthophosphoric acid
... %
231-633-27664-38-2Skin Corr. 1BH314GHS05
Dgr
H314 Skin Corr. 1B;
H314: C ≥ 25 %
Skin Irrit. 2;
H315: 10 % ≤ C < 25 %
Eye Irrit. 2; H319: 10 % ≤ C < 25 %
B
015-012-00-1tetraphosphorus trisulphide;
phosphorus sesquisulphid
215-245-01314-85-8Flam. Sol. 2
Water-react. 1
Acute Tox. 4 *
Aquatic Acute 1
H228
H260
H302
H400
GHS02
GHS07
GHS09
Dgr
H228
H260
H302
H400
  T
015-013-00-7triethyl phosphate201-114-578-40-0Acute Tox. 4 *H302GHS07
Wng
H302   
015-014-00-2tributyl phosphate204-800-2126-73-8Carc. 2
Acute Tox. 4 *
Skin Irrit. 2
H351
H302
H315
GHS08
GHS07
Wng
H351
H302
H315
   
015-015-00-8tricresyl phosphate (o–o–o-, o–o–m-, o–o–p-, o–m–m-, o–m–p-, o–p–p-);
tritolyl phosphate (o–o–o-, o–o–m-, o–o–p-, o–m–m-, o–m–p-, o–p–p-);
201-103-578-30-8STOT SE 1
Aquatic Chronic 2
H370 **
H411
GHS08
GHS09
Dgr
H370 **
H411
 STOT SE 1;
H370: C ≥ 1 %
STOT SE 2;
H371: 0,2 % ≤ C < 1%
C
015-016-00-3tricresyl phosphate (m–m–m-, m–m–p-, m–p–p-, p–p–p-);
tritolyl phosphate (m–m–m-, m–m–p-, m–p–p-, p–p–p-);
201-105-678-32-0Acute Tox. 4 *
Acute Tox. 4 *
Aquatic Chronic 2
H312
H302
H411
GHS07
GHS09
Wng
H312
H302
H411
 *C
015-019-00-Xdichlorvos (ISO);
2,2-dichlorovinyl dimethyl phosphate
200-547-762-73-7Acute Tox. 2 *
Acute Tox. 3 *
Acute Tox. 3 *
Skin Sens. 1
Aquatic Acute 1
H330
H311
H301
H317
H400
GHS06
GHS09
Dgr
H330
H311
H301
H317
H400
 M = 1000 
015-020-00-5mevinphos (ISO);
2-methoxycarbonyl-1-methylvinyl dimethyl
phosphate
232-095-17786-34-7Acute Tox. 1
Acute Tox. 2 *
Aquatic Acute 1
Aquatic Chronic 1
H310
H300
H400
H410
GHS06
GHS09
Dgr
H310
H300
H410
 M = 10000 
015-021-00-0trichlorfon (ISO);
dimethyl 2,2,2-trichloro-1-hydroxyethyl-
phosphonate
200-149-352-68-6Acute Tox. 4 *
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H302
H317
H400
H410
GHS07
GHS09
Wng
H302
H317
H400
H410
 M = 1000 
015-022-00-6phosphamidon (ISO);
2-chloro-2-diethylcarbamoyl-1-methylvinyl
dimethyl phosphate
236-116-513171-21-6Muta. 2
Acute Tox. 2 *
Acute Tox. 3 *
Aquatic Acute 1
Aquatic Chronic 1
H341
H300
H311
H400
H410
GHS06
GHS08
GHS09
Dgr
H341
H300
H311
H410
   
015-023-00-1pyrazoxon;
diethyl 3-methylpyrazol-5-yl phosphate
108-34-9Acute Tox. 2 *
Acute Tox. 1
Acute Tox. 2 *
H330
H310
H300
GHS06
Dgr
H330
H310
H300
   
015-024-00-7triamiphos (ISO);
5-amino-3-phenyl-1,2,4-triazol-1-yl-N,N,N',
N'-tetramethylphosphonic diamide
1031-47-6Acute Tox. 1
Acute Tox. 2 *
H310
H300
GHS06
Dgr
H310
H300
   
015-025-00-2TEPP (ISO);
tetraethyl pyrophosphate
203-495-3107-49-3Acute Tox. 1
Acute Tox. 2 *
Aquatic Acute 1
H310
H300
H400
GHS06
GHS09
Dgr
H310
H300
H400
   
015-026-00-8schradan (ISO);
octamethylpyrophosphoramide
205-801-0152-16-9Acute Tox. 1
Acute Tox. 2 *
H310
H300
GHS06
Dgr
H310
H300
   
015-027-00-3sulfotep (ISO);
O,O,O,O-tetraethyl dithiopyrophosphate
222-995-23689-24-5Acute Tox. 1
Acute Tox. 2 *
Aquatic Acute 1
Aquatic Chronic 1
H310
H300
H400
H410
GHS06
GHS09
Dgr
H310
H300
H410
 M = 1000 
015-028-00-9demeton-O (ISO);
O,O-diethyl-O-2-ethylthioethyl phosphorothioate
206-053-8298-03-3Acute Tox. 1
Acute Tox. 2 *
Aquatic Acute 1
H310
H300
H400
GHS06
GHS09
Dgr
H310
H300
H400